Two Sigma Investments »

AgomAb Therapeutics NV shares owned by Two Sigma Investments

Quarter-by-quarter ownership of AgomAb Therapeutics NV shares owned by Two Sigma Investments from 13F filings

Historical chart of Two Sigma Investments investment in AgomAb Therapeutics NV

Tip: Access up to 7 years of quarterly data

All positions including AgomAb Therapeutics NV held by Two Sigma Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AgomAb Therapeutics NV by Two Sigma Investments

Quarter filed Position value Share count Share price at filing
2026-03-31 $149k 14k 10.49

More positions owned by Two Sigma Investments

NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Palantir Technologies Cl A (PLTR)
Costco Wholesale Corporation (COST)
TJX Companies (TJX)
Mastercard Incorporated Cl A (MA)
Metropcs Communications (TMUS)
Lockheed Martin Corporation (LMT)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Micron Technology (MU)
Adobe Systems Incorporated (ADBE)

View all positions for Two Sigma Investments

Top funds holding AgomAb Therapeutics NV

Sanofi
Cormorant Asset Management
TCG Crossover Management
Federated Investors
Casdin Capital
Andera Partners
FMR
Nantahala Capital Management
Standard Life Aberdeen
Perceptive Advisors
Samsara BioCapital
LMR Partners
Seven Grand Managers
Redmile Group
Millennium Management

View all funds holding AgomAb Therapeutics NV